$8.395
+0.045 (+0.54%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CTNM por análisis de gráficos similares
Alphio's CTNM stock price prediction model matches the current Contineum Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.59 (+3.41%). The 1-week path is $8.19 (-1.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Contineum Therapeutics Inc?
Contineum Therapeutics Inc (CTNM) is not a good buy right now due to significant recent declines and ongoing financial losses. The current price is $7.08, which is a 47.09% drop over the past 5 days. The company has reported consistent net losses, with a net income of -$14,456,000 in Q1 2026 and an EPS of -0.39. Additionally, the RSI is extremely low at 11.66, indicating oversold conditions, but this could also suggest further downside risk. The main risk is the failure of the PIPE-307 trial, which has led to a downgrade in analyst ratings and uncertainty about future revenue streams.
CTNM cerró en $8.40 el Thursday, tras subir +0.54%
Contineum Therapeutics Inc (CTNM) last closed at $8.31, losing -1.01%. These facts feed the 1-day and 1-week CTNM price prediction above.
Factores de la previsión
Los factores de la previsión de Contineum Therapeutics Inc (CTNM) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CTNM, ordenadas por similitud.
Análisis de estacionalidad de CTNM
Historically the probability of a positive October return for CTNM is 47.62%. August offers the highest probability of a positive month at 67.19%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CTNM
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $3.06 | $3.88 | $4.41 | -53.28% |
| Nov 2026 | $3.08 | $3.92 | $3.98 | -52.88% |
| Dec 2026 | $3.75 | $4.57 | $4.88 | -45.03% |
En 2026, se proyecta que Contineum Therapeutics Inc (CTNM) oscile entre $3.06 y $4.88.
Previsión mensual de Contineum Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Contineum Therapeutics Inc promedie $3.88, con un mínimo de $3.06 y un máximo de $4.41.
En Nov de 2026, se proyecta que Contineum Therapeutics Inc promedie $3.92, con un mínimo de $3.08 y un máximo de $3.98.
En Dec de 2026, se proyecta que Contineum Therapeutics Inc promedie $4.57, con un mínimo de $3.75 y un máximo de $4.88.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.